SEC Form 4 · accession 0001104659-17-023100
AGILE THERAPEUTICS INC · AGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alfred Altomari
Officer — Chairman & Chief Exec Officer · Director
Period of report
Apr 11, 2017
Accepted (ET)
Apr 12, 2017 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001261249
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 11, 2017 | M | 30,000 | $1.76 | A | 141,587 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $1.76 | Apr 11, 2017 | M | 30,000 | D | — | Dec 8, 2020 | Common Stock | 30,000 | 144,599 | D |
Explanation of responses
- F1This option was granted on December 9, 2010 and is currently fully vested and exercisable.